Leptomeningeal melanomatosis: Stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine

Authors

  • Niklas Schaefer Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany
  • Katja Rasch Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany
  • Markus Moehlenbruch Department of Radiology, University of Bonn Medical Center, Bonn, Germany
  • Horst Urbach Department of Radiology, University of Bonn Medical Center, Bonn, Germany
  • Moritz Stuplich Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany
  • Elias Blasius Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany
  • Bjoern Scheffler Institue of Reconstructive Neurobiology, University of Bonn Medical Center, Bonn, Germany
  • Ulrich Herrlinger Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany
  • Martin Glas Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany; Institue of Reconstructive Neurobiology, University of Bonn Medical Center, Bonn, Germany

DOI:

https://doi.org/10.3109/0284186X.2011.586001

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-11-01

How to Cite

Schaefer, N., Rasch, K., Moehlenbruch, M., Urbach, H., Stuplich, M., Blasius, E., … Glas, M. (2011). Leptomeningeal melanomatosis: Stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine. Acta Oncologica, 50(8), 1260–1262. https://doi.org/10.3109/0284186X.2011.586001

Issue

Vol. 50 No. 8 (2011): Acta Oncologica

Section

Articles